US Rosacea Market Size By Product (Topical Rosacea Treatment Products, Oral Rosacea Treatment Products), By End User(Hospital, Clinic, Pharmacy) And Forecast

US Rosacea Market Size And Forecast

US Rosacea Market size was valued at USD 873.16 Billion in 2024 and is projected to reach USD 1440.74 Billion by 2031, growing at a CAGR of 6.46% from 2024 to 2031.

The advantageous regulatory requirements, corporations want to debut their goods first in the United States, which generates demand for this market. The US Rosacea Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

US Rosacea Market Definition

Rosacea is a common skin condition that produces facial redness and visible blood vessels. It mostly affects fair-skinned middle-aged women. Although there is no cure for rosacea, there are therapies that can help control and minimize the disease’s signs and symptoms.In addition, Rosacea is usually not life-threatening, although cutaneous dispersion can develop, resulting in significant demand elasticity. Therapy rates for rosacea are poor, as most people with the condition either don’t take any treatment at all or are famously non-adherent, owing to their belief that the treatment is useless.

Besides, Rosacea is a skin condition that affects only the face. Redness, swelling, pimples, and tiny and superficial dilated vessels are common symptoms of this long-term condition. It affects the nose, cheekbones, forehead, and chin, among other face features. A family history of the condition or other factors such as hot drinks and spicy foods, alcohol, temperature extremes, sunlight or wind, cold, emotions, exercise, cosmetics, drugs that dilate blood vessels, including some blood pressure medications, menopause, psychological stress, or steroid cream on the face is thought to have caused this long-term skin disease.

US Rosacea Market Overview

Some influences include the government’s annual healthcare expenditures on medications and , as well as societal awareness (several societies organizing campaigns across the US and Canada). According to the National Rosacea Society (NRS), around 16 million Americans have rosacea, with perhaps millions more in remission. Due to advantageous regulatory requirements, corporations want to debut their goods first in the United States, which generates demand for this market. Moreover, As the prevalence of cancer rises, so does public awareness among physicians and society, fueling the market’s demand.

The availability of generic medications to treat the symptoms of rosacea, on the other hand, is constraining the market’s expansion. Furthermore, Spicy meals and hot drinks, alcohol, excessive temperature changes, exercise, cosmetics, pharmaceuticals that widen blood vessels, including certain blood pressure medications, and others are all known to induce Rosacea. As a result of growing urbanization and industrialization, people are becoming more exposed to these triggers. The rising use of cosmetics, as well as a hypertensive population, are contributing to the rise in rosacea cases.

US Rosacea MarketSegmentation Analysis

The US Rosacea Market is segmented on the basis of Product And End User.

US Rosacea Market, By Product

• Topical Rosacea Treatment Products• Oral Rosacea Treatment Products

Based on Product, The market is segmented into Topical Rosacea Treatment Products and Oral Rosacea Treatment Products. Topical Rosacea Treatment Products are augmented to the growth of the US Rosacea Market due to certain points such as Your doctor may prescribe a cream or gel to apply to the afflicted skin if you have mild to moderate rosacea. By narrowing blood arteries, brimonidine (Mirvaso) and oxymetazoline (Rhofade) minimize flushing. Within 12 hours of using the product, you should observe the benefits. Because the impact on the blood vessels is only transitory, the medicine must be taken on a daily basis to sustain the benefits. For moderate to severe rosacea with bumps and pimples, your doctor may prescribe an oral antibiotic such as doxycycline (Oracea, others).

US Rosacea Market, By End User

• Hospital• Clinic• Pharmacy• Others

Based on End User, The market is segmented into Hospital, Clinic, Pharmacy, and Others. Hospital type of end user has a major share in the development of the US Rosacea Market owing to the increased awareness of so many peoples about Rosacea. Rosacea has no established origin; however, it might be caused by an overactive immune system, hereditary, environmental factors, or a combination of these. Rosacea is not infectious and is not caused by improper hygiene. This patient who is suffering from Rosacea gets well and good treatment in hospital.

Key players

The “US Rosacea Market” study report will provide valuable insight with an emphasis on the US market. The major players in the market are Nestlé S.A., Bausch Health Companies Inc., Allergan, Foamix Pharmaceuticals, Galderma, Sol-Gel Technologies, Bayer, Valeant Pharmaceuticals International. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned player’s US.

Key Developments

• In March 2022, Galderma announced the U.S. introduction of TWYNEO (tretinoin and benzoyl peroxide) Cream, 0.1 percent /3 percent. TWYNEO Cream is the first and only 2-in-1 combination of 0.1 percent tretinoin and 3% benzoyl peroxide (BPO) that has been shown to effectively treat moderate to severe face acne.

• In January 2020, A cooperative development agreement was signed between Bayer and Azitra Inc., a clinical-stage medical dermatology biotech business, for the discovery and characterization of skin microbiome bacteria.

Report Scope

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.